More than hypomyelination in pol-III disorder

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 1, 2013, Pages 67-75

  Vanderver, Adeline ^a   Tonduti, Davide ^b   Bernard, Genevieve ^c   Lai, Jinping ^d   Rossi, Christopher ^a   Carosso, Giovanni ^a   Quezado, Martha ^d   Wong, Kondi ^e   Schiffmann, Raphael ^f  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hypodontia; Hypogonadotropic hypogonadism; Hypomyelination; Leukodystrophy; Pol III

Indexed keywords

4H SYNDROME; ADULT; AIRWAY OBSTRUCTION; ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE ACTIVITY; GENE; GENETIC DISORDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKODYSTROPHY; MACROPHAGE; MALE; NERVE BIOPSY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; POLR3A GENE; PRIORITY JOURNAL; SCHOOL CHILD;

ADULT; ANODONTIA; ATAXIA; DNA POLYMERASE III; FATAL OUTCOME; HUMANS; HYPOGONADISM; LEUKOENCEPHALOPATHIES; MALE;

EID: 84871987430     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31827c99d2     Document Type: Article

References (38)

1. Bernard G, Chouery E, Putorti ML, et al. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet 2011;89:415-23
2. Timmons M, Tsokos M, Asab MA, et al. Peripheral and central hypomyelination with hypogonadotropic hypogonadism and hypodontia. Neurology 2006;67:2066-69
3. Atrouni S, Darazé A, Tamraz J, et al. Leukodystrophy associated with oligodontia in a large inbred family: Fortuitous association or new entity? Am J Med Genet A 2003;118:76-81
4. Sato I, Onuma A, Goto N, et al. A case with central and peripheral hypomyelination with hypogonadotropic hypogonadism and hypodontia (4H syndrome) plus cataract. J Neurol Sci 2011;300:179-81
5. Wolf NI, Harting I, Innes AM, et al. Ataxia, delayed dentition and hypomyelination: A novel leukoencephalopathy. Neuropediatrics 2007;38:64-70
6. Tetreault M, Choquet K, Orcesi S, et al. Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy. Am J Hum Genet 2011;89:652-55
7. Bernard G, Chouery E, Putorti ML, et al. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet 2011;89:415-23
8. Saitsu H, Osaka H, Sasaki M, et al. Mutations in POLR3A and POLR3B encoding RNA polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am J Hum Genet 2011;89:644-51
9. Wolff A, Koch MJ, Benzinger S, et al. Rare dental peculiarities associated with the hypomyelinating leukoencephalopathy 4H syndrome/ADDH. Pediatr Dent 2010;32:386-92
10. Vazquez-Lopez M, Ruiz-Martín Y, de Castro-Castro P, et al. Central hypomyelination, hypogonadotrophic hypogonadism and hypodontia: A new leukodystrophy [In Spanish]. Rev Neurol 2008;47:204-8
11. Outteryck O, Devos D, Jissendi P, et al. 4H syndrome: A rare cause of leukodystrophy. J Neurol 2010;257:1759-61
12. Orcesi S, Tonduti D, Uggetti C, et al. New case of 4H syndrome and a review of the literature. Pediatr Neurol 2010;42:359-64
13. Bekiesinska-Figatowska M, Mierzewska H, Kuczynska-Zardzewialy A, et al. Hypomyelination, hypogonadotropic hypogonadism, hypodontiaV First Polish patient. Brain Dev 2010;32:574-78
14. Chouery E, Delague V, Jalkh N, et al. A whole-genome scan in a large family with leukodystrophy and oligodontia reveals linkage to 10q22. Neurogenetics 2010;12:73-78
15. Bernard G, Thiffault I, Tetreault M, et al. Tremor-Ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3Y 10q23.31. Neurogenetics 2010;11:457-64
16. Schiffmann R, van der Knaap MS. Invited article: An MRI-based approach to the diagnosis of white matter disorders. Neurology 2009;72:750-59
17. Steenweg ME, Vanderver A, Blaser S, et al. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain 2010;133:2971-82
18. de Souza A, Desai PK. More often striatal myelinolysis than pontine? A consecutive series of patients with osmotic demyelination syndrome. Neurol Res 2012;34:262-71
19. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009;138:576-91
20. Tyynelä J, Cooper JD, Khan MN, et al. Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: Distinct patterns of storage deposition, neurodegeneration and glial activation. Brain Pathol 2004;14: 349-57
21. Wong K, Sidransky E, Verma A, et al. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 2004;82: 192-207
22. Potic A, Brais B, Choquet K, et al. 4H syndrome with late-onset growth hormone deficiency caused by POLR3A mutations. Arch Neurol 2012; 69:920-23
23. Terao Y, Saitsu H, Segawa M, et al. Diffuse central hypomyelination presenting as 4H syndrome caused by compound heterozygous mutations in POLR3A encoding the catalytic subunit of polymerase III. J Neurol Sci 2012;320:102-5
24. Szymanski M, Barciszewska MZ, Erdmann VA, et al. 5 S rRNA: Structure and interactions. Biochem J 2003;371:641-51
25. Dieci G, Fiorino G, Castelnuovo M, et al. The expanding RNA polymerase III transcriptome. Trends Genet 2007;23:614-22
26. Jeronimo C, Forget D, Bouchard A, et al. Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Mol Cell 2007;27:262-74
27. Krueger BJ, Jeronimo C, Roy BB, et al. LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated. Nucleic Acids Res 2008;36:2219-29
28. Feinstein M, Markus B, Noyman I, et al. Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation. Am J Hum Genet 2010; 87:820-28
29. Edvardson S, Shaag A, Kolesnikova O, et al. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 2007;81:857-62
30. Scheper GC, van der Klok T, van Andel RJ, et al. Mitochondrial aspartyltRNA synthetase deficiency causes leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation. Nat Genet 2007;39: 534-39
31. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 2002;200:629-38
32. Errede M, Girolamo F, Ferrara G, et al. Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol 2012;71:840-54
33. Nico B, Ribatti D. Morphofunctional aspects of the blood-brain barrier. Curr Drug Metab 2012;13:50-60
34. Denis J, Delorme ML, Boschat M, et al. Respective roles of ammonia, amino acids, and medium-sized molecules in the pathogenesis of experimentally induced acute hepatic encephalopathy. J Neurochem 1983;40: 10-19
35. Deguchi T, Isozaki K, Yousuke K, et al. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier. J Neurochem 2006;96:1051-59
36. Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab 2012;32:1959-72
37. Ge Y, Law M, Herbert J, et al. Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. AJNR Am J Neuroradiol 2005;26:2316-19
38. Alvarez JI, Dodelet-Devillers A, Kebir H, et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 2011;334:1727-31.